Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frits van Rhee

Showing results (31-40 of 274) with videos related to

Pageof 28
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 20, 2021
Ehrlichia-induced hemophagocytic lymphohistiocytosis after autologous stem cell transplantAngel A Mitma, Mary J Burgess, Frits van Rhee
Leukemia & Lymphoma|June 14, 2003
Predicting long-term survival in multiple myeloma patients following autotransplantsAthanasios B T Fassas, Frits Van Rhee, Guido Tricot
Current Oncology Reports|February 12, 2025
Current State of Evidence on Definitions and Management of High-Risk Multiple MyelomaBhavesh Mohan Lal, Frits van Rhee, Samer Al Hadidi
Expert Opinion on Biological Therapy|July 9, 2026
Treating Castleman disease: insights into the use and efficacy of monoclonal antibodiesYoshito Nishimura, Thomas Habermann, Angela Dispenzieri, et al.
Ejhaem|May 19, 2023
Acquired hemophilia A (AHA) due to anti-SARS-CoV-2 vaccination: A systematic reviewFnu Amisha, Prachi Saluja, Paras Malik, et al.
Blood|March 14, 2014
HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapyDavid C Fajgenbaum, Frits van Rhee, Christopher S Nabel
Clinical Lymphoma, Myeloma & Leukemia|January 19, 2016
Atrial Fibrillation in Hematologic Malignancies, Especially After Autologous Hematopoietic Stem Cell Transplantation: Review of Risk Factors, Current Management, and Future DirectionsPankaj Mathur, Hakan Paydak, Sharmilan Thanendrarajan, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 13, 2024
Cereblon E3 Ligase Modulators Mezigdomide and Iberdomide in Multiple MyelomaTanvi H Patel, Frits van Rhee, Samer Al Hadidi
Cancers|December 24, 2021
Epigenetic Deregulation of Telomere-Related Genes in Newly Diagnosed Multiple Myeloma PatientsSamrat Roy Choudhury, Cody Ashby, Fenghuang Zhan, et al.
Diagnostic Pathology|February 22, 2018
Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencingJonathon H Gralewski, Ginell R Post, Frits van Rhee, et al.
Pageof 28

Showing results (31-40 of 274) with videos related to

Sort By:
Pageof 28
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 20, 2021
Ehrlichia-induced hemophagocytic lymphohistiocytosis after autologous stem cell transplantAngel A Mitma, Mary J Burgess, Frits van Rhee
Leukemia & Lymphoma|June 14, 2003
Predicting long-term survival in multiple myeloma patients following autotransplantsAthanasios B T Fassas, Frits Van Rhee, Guido Tricot
Current Oncology Reports|February 12, 2025
Current State of Evidence on Definitions and Management of High-Risk Multiple MyelomaBhavesh Mohan Lal, Frits van Rhee, Samer Al Hadidi
Expert Opinion on Biological Therapy|July 9, 2026
Treating Castleman disease: insights into the use and efficacy of monoclonal antibodiesYoshito Nishimura, Thomas Habermann, Angela Dispenzieri, et al.
Ejhaem|May 19, 2023
Acquired hemophilia A (AHA) due to anti-SARS-CoV-2 vaccination: A systematic reviewFnu Amisha, Prachi Saluja, Paras Malik, et al.
Blood|March 14, 2014
HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapyDavid C Fajgenbaum, Frits van Rhee, Christopher S Nabel
Clinical Lymphoma, Myeloma & Leukemia|January 19, 2016
Atrial Fibrillation in Hematologic Malignancies, Especially After Autologous Hematopoietic Stem Cell Transplantation: Review of Risk Factors, Current Management, and Future DirectionsPankaj Mathur, Hakan Paydak, Sharmilan Thanendrarajan, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 13, 2024
Cereblon E3 Ligase Modulators Mezigdomide and Iberdomide in Multiple MyelomaTanvi H Patel, Frits van Rhee, Samer Al Hadidi
Cancers|December 24, 2021
Epigenetic Deregulation of Telomere-Related Genes in Newly Diagnosed Multiple Myeloma PatientsSamrat Roy Choudhury, Cody Ashby, Fenghuang Zhan, et al.
Diagnostic Pathology|February 22, 2018
Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencingJonathon H Gralewski, Ginell R Post, Frits van Rhee, et al.
Pageof 28